Weight management and metabolic peptides are extensively researched for their roles in appetite-signalling pathways, lipolysis mechanisms, and metabolic rate regulation in laboratory models.
This category features Semaglutide and Tirzepatide, GLP-1 receptor agonists studied for incretin pathway research; AOD-9604, a modified growth hormone fragment investigated for fat metabolism without affecting IGF-1 levels; Retatrutide, a triple-agonist peptide explored for GLP-1, GIP, and glucagon receptor interactions; and Tesamorelin, a GHRH analogue studied for visceral adipose tissue models.
Also available: 5-Amino-1MQ, MOTS-c, and CJC-1295/Ipamorelin combinations used in metabolic research protocols.
For laboratory and research use only. Not for human consumption.

